GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.
For investor information, please contact IR@genmarkdx.com.
May 5, 2015
GenMark Diagnostics Reports Q1 Financial Results
May 13, 2015 at 3:00 PM PT
Bank of America Merrill Lynch 2015 Health Care Conference
May 5, 2015 at 4:30 PM ET
GenMark Diagnostics First Quarter Earnings Conference Call